Anuh Pharma Limited

Web: anuhpharma.com NSE: ANUHPHR BSE: 506260 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

81 2(2%)

Volume

2L as on 23, Jun

Open

212

High

224

Low

211

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

28/100

Growth Score

21/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

815

No. of Shares

P/E

17.66

P/B

3.58

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

20.27

ROCE

Profit Growth

Listing Date

20-Dec-24

Promoter Holding

71.79%

FII Holding

0.01%

DII Holding

Price Chart

Price Performance

1 Week2%

1 Month4%

3 Months10%

6 Months3%

1 Year3%

YTD3%

Moving Average

5 Day SMA79

10 Day SMA78

20 Day SMA77

30 Day SMA78

50 Day SMA79

61 Day SMA78

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	81	79	81	82
Resistance 2	81	79	80	81
Resistance 1	80	79	80	80
Pivot Point	79	79	79	79
Support 1	78	79	78	79
Support 2	77	78	78	78
Support 3	77	78	77	77

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jul 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 71.79%	(0.01) 71.79%	(0.01) 71.81%	(1.91) 71.81%	(0.01) 69.91%	(0.01) 69.91%	(0.01) 69.91%	(0.01) 69.91%	(0.01) 69.91%	(0.01) 69.91%	(0.01) 69.91%	(-0.71) 69.94%	(0.01) 70.59%	(0.01) 70.59%	(0.01) 70.59%	(0.01) 70.59%	(0.01) 70.59%	(0.21) 70.59%	(0.01) 70.43%	(0.01) 70.45%
FIIs	(0.01) 0.01%	(0.11) 0.05%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.03%	(0.01) 0.04%	(0.01) 0.04%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.03%	(0.01) 0.03%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(0.11) 0.10%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	28.19%	28.14%	28.17%	28.19%	30.05%	30.04%	30.04%	30.07%	30.06%	30.05%	29.96%	30.05%	29.40%	29.39%	29.40%	29.40%	29.41%	29.42%	29.56%	29.55%
No. of Shareholders	27,484	27,425	27,889	28,250	26,157	24,257	24,235	24,279	23,910	23,494	22,237	20,519	19,066	19,423	19,969	20,470	20,452	20,740	21,123	21,500

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	194	202	197	186	186	198	160	166	138	164	172	150	161	157	139	115.07	116.38	129	132	109
Sales Growth % (YoY)	3.9%	2%	23.6%	12%	35.2%	20.9%	-7.3%	11%	-14.6%	4.2%	24%	30%	38.8%	22%	5.4%	5.8%	-0.8%	32.8%	33.9%	-3.1%
Sales Growth % (QoQ)	-4%	2.5%	5.9%	-	-6.1%	23.8%	-3.6%	20.3%	-15.9%	-4.7%	14.7%	-6.8%	2.5%	12.9%	20.8%	-1.1%	-9.8%	-2.3%	21.1%	-
Expenses	178	182	178	174	176	179	145	149	127	145	148	132	148	143	126	101.64	105.2	115	120	96
Operating Profit	16	20	19	12	10	19	15	17	11	19	24	18	14	14	12	13.43	11.18	14	12	12
OPM %	8	10	10	6	6	9	9	10	8	12	14	12	9	9	9	11.67	9.61	11	9	11
Other Income	3	-1	2	1	3	1	1	3	4	3	4	2	3	1	2	2.01	0.96	1	0	2
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.11	0.06	0	1	0
Depreciation	2	3	3	3	3	3	2	2	2	2	2	2	2	2	2	2.44	2.42	3	3	3
Profit before tax	17	16	18	10	11	17	13	18	12	20	25	18	15	13	12	12.89	9.66	12	9	11
Tax %	32	25	25	23	24	28	22	17	22	22	24	23	24	25	23	23.04	24.12	26	16	22
Net Profit	11	12	13	8	8	12	10	15	10	15	19	14	12	10	9	9.92	7.34	9	7	9
Net Profit Growth % (QoQ)	-8.3%	-7.7%	62.5%	-	-33.3%	20%	-33.3%	50%	-33.3%	-21.1%	35.7%	16.7%	20%	11.1%	-9.3%	35.1%	-18.4%	28.6%	-22.2%	-
Net Profit Growth % (YoY)	37.5%	-	30%	-46.7%	-20%	-20%	-47.4%	7.1%	-16.7%	50%	111.1%	41.1%	63.5%	11.1%	28.6%	10.2%	-	-	-	-
TTM Net Profit	44	41	41	38	45	47	50	59	58	60	55	45	40.92	36.26	35.26	33.26	32.34	25	16	0
EPS in Rs	1.14	1.17	1.34	0.76	0.83	1.24	1.03	1.5	0.95	1.53	1.91	1.38	1.17	0.96	0.93	0.99	0.73	0.89	1.49	1.72

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	772	662	647	527	487	432	307	321	238	206	326	284	266	243
Sales Growth %	16.6%	2.2%	22.7%	8.4%	12.7%	40.7%	-4.3%	34.7%	15.5%	-36.8%	15%	6.5%	9.7%	7.3%
Expenses	709	600	571	476	439	387	284	291	220	183	289	253	242	225
Operating Profit	62	62	76	52	47	45	23	30	18	23	38	31	24	18
OPM %	8	9	12	10	10	10	8	9	8	11	12	11	9	7
Other Income	4	9	12	6	5	11	4	5	7	8	4	5	4	2
Interest	1	1	1	1	2	2	1	1	0	1	1	1	1	1
Depreciation	11	9	9	10	12	15	7	2	2	2	2	3	2	2
Profit before tax	54	61	78	47	39	39	19	32	23	28	38	32	25	18
Tax %	24	22	23	24	22	26	25	28	29	27	32	31	31	29
Net Profit	41	47	60	36	31	28	14	23	17	20	26	22	18	13
Net Profit Growth %	-12.8%	-21.7%	66.7%	16.1%	10.7%	100%	-39.1%	35.3%	-15%	-23.1%	18.2%	22.2%	38.5%	-
EPS in Rs	4.1	4.73	5.99	3.61	3.05	2.84	1.43	2.33	1.65	2	2.57	2.19	1.76	2.5
Dividend Payout %	37	16	21	28	29	26	48	29	42	31	24	27	37	40

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	-3	37	13	54	29	-19	49	7	2	26	16	19	15	2
Cash from Investing Activity	18	-20	1	-43	-8	52	-77	3	2	-20	-5	-12	-5	4
Cash from Financing Activity	-26	-5	-9	-12	-19	-33	22	-7	-5	-4	-9	-8	-8	-6
Net Cash Flow	-12	12	5	-2	2	0	-5	3	-1	2	2	-1	2	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	50	50	25	25	25	25	25	25	13	13	13	13	13	4	4	4
Reserves	302	277	301	278	266	216	189	166	150	152	137	128	107	97	82	71
Borrowings	0	0	11	14	3	1	4	14	45	4	2	0	2	0	0	1
Other Liabilities	205	182	170	117	152	163	129	128	119	71	57	48	71	67	77	60
Total Liabilities	557	509	507	434	446	405	347	333	326	240	209	189	193	168	163	136
Fixed Assets	57	61	58	46	49	53	61	71	84	21	17	17	18	9	12	10
CWIP	0	1	0	2	0	0	0	0	0	34	6	0	0	0	0	3
Investments	84	71	106	98	97	91	43	31	80	39	66	70	43	43	27	19
Other Assets	416	376	342	288	300	261	243	230	163	147	120	101	131	116	124	104
Total Assets	557	509	507	434	446	405	347	333	326	240	209	189	193	168	163	136

Delivery

Delivery Data: ANUHPHR

#	Date	75 14% 86	Value (Cr)	Q/T 82	Del 61	Del 1
1	4-Sep	81	1	57	64	0
2	3-Sep	80	1	68	60	0
3	2-Sep	79	1	76	55	1
4	1-Sep	81	1	47	48	0
5	31-Aug	82	0	38	57	0
6	28-Aug	84	1	56	58	1
7	27-Aug	84	3	87	60	2
8	26-Aug	79	0	47	63	0
9	25-Aug	77	0	40	70	0
10	24-Aug	79	1	47	61	0
11	21-Aug	76	0	58	71	0
12	20-Aug	76	0	46	73	0
13	19-Aug	76	0	69	81	0
14	18-Aug	76	0	48	76	0
15	17-Aug	76	0	74	88	0
16	14-Aug	76	0	59	79	0
17	13-Aug	77	0	49	80	0
18	12-Aug	77	1	84	82	0
19	11-Aug	78	1	136	84	1
20	10-Aug	78	1	121	83	1
21	7-Aug	79	1	50	50	0
22	6-Aug	79	0	142	89	0
23	5-Aug	79	0	52	65	0
24	4-Aug	80	0	51	59	0
25	3-Aug	80	0	52	61	0
26	31-Jul	79	0	32	65	0
27	30-Jul	80	0	45	68	0
28	29-Jul	79	0	56	71	0
29	28-Jul	80	0	38	59	0
30	27-Jul	81	0	44	64	0
31	24-Jul	79	0	55	53	0
32	23-Jul	79	0	45	62	0
33	22-Jul	81	0	50	63	0
34	21-Jul	80	0	50	67	0
35	20-Jul	81	0	62	64	0
36	17-Jul	79	0	56	67	0
37	16-Jul	80	0	42	65	0
38	15-Jul	80	0	50	58	0
39	14-Jul	80	0	31	62	0
40	13-Jul	79	0	28	57	0
41	10-Jul	79	0	24	48	0
42	9-Jul	79	0	23	54	0
43	8-Jul	77	0	62	56	0
44	7-Jul	79	0	80	76	0
45	6-Jul	80	1	46	50	0
46	3-Jul	80	1	56	51	0
47	2-Jul	81	1	49	34	0
48	1-Jul	80	0	41	66	0
49	30-Jun	81	1	55	73	0
50	29-Jun	80	1	87	46	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	815c	12c	1.52
03-Sep	803c	19c	2.33
01-Sep	822c	3c	0.38
31-Aug	825c	47c	6.06
26-Aug	778c	4c	0.47
25-Aug	782c	9c	1.17
24-Aug	791c	28c	3.67
21-Aug	763c	1c	0.14
19-Aug	762c	0	0
18-Aug	762c	3c	0.38
17-Aug	759c	4c	0.53
14-Aug	763c	13c	1.72
13-Aug	776c	1c	0.14
12-Aug	777c	4c	0.45
11-Aug	781c	20L	0.03
10-Aug	781c	11c	1.35
06-Aug	792c	10c	1.23
04-Aug	802c	6c	0.72
31-Jul	796c	30L	0.04
30-Jul	796c	6c	0.80
29-Jul	803c	70L	0.09
28-Jul	802c	15c	1.84
27-Jul	817c	0	0

Stock Checklist

Price is above from 52 week high low average: 55%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.00%	-0.01%	0

Anuh Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements